骨髓瘤中BRAF突变:发生率和临床结果
Tareq Abuasab1, Shehab Mohamed1, Naveen Pemmaraju1
1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Leukemia & lymphoma
|May 2, 2024
概括
BRAF突变在髓瘤 (MNs) 中很少见,但可以作为驱动突变. 通过治疗清除这些BRAF突变可以显著改善患者的生存结果.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 作为骨髓瘤 (MNs) 的驱动突变,BRAF突变的作用还未得到充分研究,特别是在毛细胞白血病之外.
- 在固体瘤中,BRAF突变很常见,但它们在多种瘤中的患病率和影响需要进一步调查.
研究的目的:
- 调查BRAF突变MNS的患者的特征和结果.
- 评估BRAF突变作为MNs潜在驱动突变的意义.
主要方法:
- 对6667名患有骨髓瘤瘤的患者的大队伍的回顾性分析.
- 鉴定和描述BRAF突变及其与患者人口统计,遗传景观和临床结果的相关性.
主要成果:
- 在0.7% (48/6667) 的MN患者中发现了BRAF突变. 三名患有单独BRAF突变的患者支持其作为驱动突变的作用.
- 发生BRAF突变的MN,特别是在急性髓性白血病中,通常与二次AML,低风险细胞遗传学和RAS通路共同突变有关.
- 在疾病进展过程中获得BRAF突变并没有影响结果,但通过治疗其清除与改善的整体存活率相关 (34.8 vs 10.4 个月,p=0.047).
- 在MNs中,G469A BRAF突变最常见,与V600E在固体瘤和毛细胞白血病中占主导地位形成鲜明对比.
结论:
- 虽然很少见,但BRAF突变可能是MNS的驱动突变.
- 治疗诱导的BRAF突变清除与MN患者的显著改善结果有关.
- 在MNs中BRAF的突变概况不同于在固体瘤和毛细胞白血病中观察到的,这表明了不同的致癌机制.
更多相关视频
08:18Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma
Published on: September 8, 2021
2.9K
06:44Author Spotlight: Integrating BRET-Based Assays and Rare Mutation Analysis to Decipher RAF Kinase Regulation in Live Cells
Published on: March 1, 2024
1.0K
相关概念视频
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
01:20The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
02:38The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K